Calycosin as a Novel PI3K Activator Reduces Inflammation and Fibrosis in Heart Failure Through AKT-IKK/STAT3 Axis.
Wang X, Li W, Zhang Y, Sun Q, Cao J, Tan N, Yang S, Lu L, Zhang Q, Wei P, Ma X, Wang W, Wang Y.
Wang X, et al. Among authors: zhang q, zhang y.
Front Pharmacol. 2022 Feb 21;13:828061. doi: 10.3389/fphar.2022.828061. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35264961
Free PMC article.